inflammatory signaling in the pathogenesis of mds
Published 2 years ago • 71 plays • Length 3:19Download video MP4
Download video MP3
Similar videos
-
1:59
the role of inflammatory signaling pathways in lower-risk mds
-
3:06
the role of chronic inflammation in lower-risk mds and future therapeutic strategies
-
2:49
the role of the immune system in the pathophysiology of mds
-
1:32
the role of the innate immune system in mds pathogenesis
-
14:25
an overview of novel innovative treatments for patients with von willebrand disease
-
1:53
the role of chronic inflammation in clonal hematopoiesis and the development of mds
-
1:41
an overview of the mds diagnosis pathway
-
2:03
molecular pathogenesis and immune dysregulation in mds
-
17:04
mds - myelodysplastic syndrome
-
6:45
clonal hematopoiesis of indeterminate potential as a novel risk factor for stroke
-
6:33
myelodysplastic syndromes - causes, symptoms, diagnosis, treatment, pathology
-
1:30
the prognostic value of patient-reported outcomes in mds
-
6:05
the immune system's role in higher-risk mds
-
1:37
the role of the innate immune system in mds & the value of targeting immune signaling pathways
-
1:24
mm-6 study: in-class transition to a regimen of ixazomib, lenalidomide, & dexamethasone for myeloma
-
2:56
innate immunity in mds pathogenesis
-
1:58
innate immunity in mds pathogenesis
-
1:16
state of the art: mds
-
5:36
mds biology: somatic mutations, the microenvironment & inflammation
-
1:37
a phase i/ii trial of seclidemstat in combination with azacitidine for patients with mds and cmml
-
2:47
molecular background studies to aid diagnosis and treatment of mds
-
2:43
novel therapies in the future of mds treatment